Semnur Pharmaceuticals (SMNR) Preferred Stock Liabilities (2022 - 2025)
Semnur Pharmaceuticals (SMNR) recorded Preferred Stock Liabilities of $548,318 in Q2 2025, down 98.9% from $52.07 million a year earlier and down 94.0% from the prior quarter.
Powered by 
Analysis
Semnur Pharmaceuticals (SMNR) Preferred Stock Liabilities (2022 - 2025) Analysis & Trends
At the end of FY2024, Semnur Pharmaceuticals reported Preferred Stock Liabilities of $9.02 million, down 82.1% from FY2023.
- Across earlier years, Preferred Stock Liabilities came in at $50.48 million in FY2023 (-40.9%) and $85.37 million in FY2022.
- The Q2 2025 figure is the lowest quarterly Preferred Stock Liabilities in data going back to Q2 2022.
- On a year-over-year basis, Preferred Stock Liabilities has declined for seven consecutive quarters, with an average decline of 58.7% over the last eight quarters.
- Peak year-over-year performance for Preferred Stock Liabilities in the last five years was growth of 6.5% in Q3 2023, against a decline of 98.9% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $9.15 million (Q1 2025), $9.02 million (Q4 2024) and $8.89 million (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | - |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Semnur Pharmaceuticals | 85.18 Mn | 84.92 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 548,318.00 |
| Mar 31, 2025 | 9.15 Mn |
| Dec 31, 2024 | 9.02 Mn |
| Sep 30, 2024 | 8.89 Mn |
| Jun 30, 2024 | 52.07 Mn |
| Mar 31, 2024 | 51.28 Mn |
| Dec 31, 2023 | 50.48 Mn |
| Sep 30, 2023 | 90.11 Mn |
| Jun 30, 2023 | 88.14 Mn |
| Mar 31, 2023 | 86.28 Mn |
| Dec 31, 2022 | 85.37 Mn |
| Sep 30, 2022 | 84.65 Mn |
| Jun 30, 2022 | 84.15 Mn |
API Access
Semnur Pharmaceuticals Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SMNR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "SMNR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SMNR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();